Lexaria Bioscience
Price & Volume
Stats
See more52W Range | $0.46-$1.55 |
Market Cap | $16.1M |
Shares Short | 346,201 |
Financials
See moreRevenue (12 Mos) | $368,000 |
Revenue Growth (YoY) | -88.5% |
Gross Profit (12 Mos) | $368,000 |
Diluted EPS | -$0.47 |
News
See moreYahoo Finance • 7 days ago
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
Yahoo Finance • 21 days ago
Lexaria Updates Progress on Human Study #7
Yahoo Finance • 2 months ago
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
Yahoo Finance • 7 months ago
Lexaria Bioscience files to sell 2.76M shares of common stock for holders
About
CEO | Mr. Richard C. Christopher |
Address | 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |